Remote ischemic preconditioning in non-cardiac surgery (PRINCE): a multinational, double blind, sham-controlled, randomized clinical trial

Remote ischemic preconditioning (RIPC) is a clinical procedure aimed at inducing myocardial protection by causing brief ischemia-reperfusion episodes in an organ remote from the heart. We aim to assess whether RIPC provides myocardial protection in patients undergoing non-cardiac surgery. This study, called remote ischemic PReconditioning In Non-Cardiac surgEry (PRINCE), is a double-blind, multinational randomized clinical trial (1:1 allocation ratio) which plans to enroll 1100 patients. The intervention arm will receive RIPC at the beginning of surgery by inflating a blood pressure cuff around a limb for three cycles of ten minutes (inflated cuff for five minutes followed by deflated cuff for five minutes). In the control group, a blood pressure cuff will be put on a limb, and a sham inflation will be performed. Given a potential interaction of propofol with RIPC, induction and maintenance of anesthesia will be performed without propofol. The primary endpoint of the study is to document a significant reduction in postoperative cardiac troponin values among patients receiving RIPC. Secondary endpoints will be cardiac ischemic events at 30 days and 1 year, mortality at 30 days and 1 year, neurologic events at 30 days and 1 year, acute kidney injury at 7 days, need for intensive care unit admission and length of hospital stay. The trial will provide evidence for the effects of RIPC on cardioprotection and other relevant outcomes in high-cardiac risk patients undergoing non-cardiac surgery. Clinical Trial Registration: NCT02427867.

Remote ischemic preconditioning; Non-cardiac surgery; Cardioprotection

[1] Weiser TG, Haynes AB, Molina G, Lipsitz SR, Esquivel MM, Uribe-Leitz T, et al. Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes. The Lancet. 2015; 385: S11.

[2] Sazgary L, Puelacher C, Lurati Buse G, Glarner N, Lampart A, Bolliger D, et al. Incidence of major adverse cardiac events following non-cardiac surgery. European Heart Journal. Acute Cardiovascular Care. 2021; 10: 550–558.

[3] Khan J, Alonso-Coello P, Devereaux PJ. Myocardial injury after noncardiac surgery. Current Opinion in Cardiology. 2014; 29: 307–311.

[4] Writing Committee for the VISION Study Investigators; Devereaux PJ, Biccard BM, Sigamani A, Xavier D, Chan MTV, Srinathan SK, et al. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2017; 317: 1642–1651.

[5] Przyklenk K, Whittaker P. Remote ischemic preconditioning: current knowledge, unresolved questions, and future priorities. Journal of Cardiovascular Pharmacology and Therapeutics. 2011; 16: 255–259.

[6] Wu Q, Wang T, Chen S, Zhou Q, Li H, Hu N, et al. Cardiac protective effects of remote ischaemic preconditioning in children undergoing tetralogy of fallot repair surgery: a randomized controlled trial. European Heart Journal. 2018; 39: 1028–1037.

[7] Xie J, Liao X, Chen W, Huang D, Chang F, Chen W, et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing heart valve surgery: randomised controlled trial. Heart. 2012; 98: 384–388.

[8] Han R, Liu X, Yin X, Zheng M, Sun K, Liu X, et al. Effect of remote ischemic preconditioning on myocardial injury and inflammatory response induced by ablation for atrial fibrillation: a randomized controlled trial. International Journal of Cardiology. 2016; 222: 396–400.

[9] Slagsvold KH, Moreira JB, Rognmo O, Høydal M, Bye A, Wisløff U, et al. Remote ischemic preconditioning preserves mitochondrial function and activates pro-survival protein kinase Akt in the left ventricle during cardiac surgery: a randomized trial. International Journal of Cardiology. 2014; 177: 409–417.

[10] Venugopal V, Hausenloy DJ, Ludman A, Di Salvo C, Kolvekar S, Yap J, et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomised controlled trial. Heart. 2009; 95: 1567–1571.

[11] Davies WR, Brown AJ, Watson W, McCormick LM, West NE, Dutka DP, et al. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up. Circulation. Cardiovascular Interventions. 2013; 6: 246–251.

[12] Thielmann M, Kottenberg E, Kleinbongard P, Wendt D, Gedik N, Pasa S, et al. Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. The Lancet. 2013; 382: 597–604.

[13] Smilowitz NR, Gupta N, Ramakrishna H, Guo Y, Berger JS, Bangalore S. Perioperative major adverse cardiovascular and cerebrovascular events associated with noncardiac surgery. JAMA Cardiology. 2017; 2: 181–187.

[14] Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, et al.; American College of Cardiology; American Heart Association. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery–executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Journal of the American College of Cardiology. 2002; 39: 542–553.

[15] Bunte S, Behmenburg F, Eckelskemper F, Mohr F, Stroethoff M, Raupach A, et al. Cardioprotection by humoral factors released after remote ischemic preconditioning depends on anesthetic regimen. Critical Care Medicine. 2019; 47: e250–e255.

[16] Kottenberg E, Thielmann M, Bergmann L, Heine T, Jakob H, Heusch G, et al. Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol—a clinical trial. Acta Anaesthesiologica Scandinavica. 2012; 56: 30–38.

[17] Kotani Y, Pruna A, Landoni G. Mechanisms of action of the detrimental effects of propofol on survival. Journal of Cardiothoracic and Vascular Anesthesia. 2023; 37: 2176–2180.

[18] Kotani Y, Pruna A, Turi S, Borghi G, Lee TC, Zangrillo A, et al. Propofol and survival: an updated meta-analysis of randomized clinical trials. Critical Care. 2023; 27: 139.

[19] Dripps RD. New classification of physical status. Anesthesiology. 1963; 24: 111.

[20] New York Heart Association Criteria Committee. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th edn. Little, Brown & Co: Boston. 1994.

[21] Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al.; ESC Scientific Document Group. Fourth universal definition of myocardial infarction (2018). European Heart Journal. 2018; 40: 237–269.

[22] Thygesen K, Mair J, Giannitsis E, Mueller C, Lindahl B, Blankenberg S, et al.; Study Group on Biomarkers in Cardiology of ESC Working Group on Acute Cardiac Care. How to use high-sensitivity cardiac troponins in acute cardiac care. European Heart Journal. 2012; 33: 2252–2257.

[23] Apple FS, Jaffe AS, Collinson P, Mockel M, Ordonez-Llanos J, Lindahl B, et al.; International Federation of Clinical Chemistry (IFCC) Task Force on Clinical Applications of Cardiac Bio-Markers. IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clinical Biochemistry. 2015; 48: 201–203.

[24] Kotnik G, Mežnar M, Golmajer M, Voga G, Podbregar M. Importance of myocardial ischemia detected with protocol-based measurements of high-sensitivity troponin, ECG and echocardiography in critically ill patients without acute coronary syndrome—a prospective study. Signa Vitae. 2022; 18: 81–90.

[25] Kim M, Son M, Lee DH, Park K, Park TH. Troponin-I level after major noncardiac surgery and its association with long-term mortality. International Heart Journal. 2016; 57: 278–284.

[26] Jammer I, Wickboldt N, Sander M, Smith A, Schultz MJ, Pelosi P, et al.; European Society of Anaesthesiology (ESA) and the European Society of Intensive Care Medicine (ESICM); European Society of Anaesthesiology; European Society of Intensive Care Medicine. Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome measures. European Journal of Anaesthesiology. 2015; 32: 88–105.

[27] Ekeloef S, Homilius M, Stilling M, Ekeloef P, Koyuncu S, Münster AB, et al. The effect of remote ischaemic preconditioning on myocardial injury in emergency hip fracture surgery (PIXIE trial): phase II randomised clinical trial. The BMJ. 2019; 367: l6395.

[28] Haller G, Bampoe S, Cook T, Fleisher LA, Grocott MPW, Neuman M, et al.; StEP-COMPAC Group. Systematic review and consensus definitions for the standardised endpoints in perioperative medicine initiative: clinical indicators. British Journal of Anaesthesia. 2019; 123: 228–237.

[29] Chapter 1: definition and classification of CKD. Kidney International Supplements. 2013; 3: 19–62.

[30] Glance LG, Benesch CG, Holloway RG, Thirukumaran CP, Nadler JW, Eaton MP, et al. Association of time elapsed since ischemic stroke with risk of recurrent stroke in older patients undergoing elective nonneurologic, noncardiac surgery. JAMA Surgery. 2022; 157: e222236.

[31] Prowle JR, Forni LG, Bell M, Chew MS, Edwards M, Grams ME, et al. Postoperative acute kidney injury in adult non-cardiac surgery: joint consensus report of the acute disease quality initiative and perioperative quality initiative. Nature reviews. Nephrology. 2021; 17: 605–618.

[32] Wahlstrøm KL, Bjerrum E, Gögenur I, Burcharth J, Ekeloef S. Effect of remote ischaemic preconditioning on mortality and morbidity after non-cardiac surgery: meta-analysis. BJS Open. 2021; 5: zraa026.

[33] Ackland GL, Abbott TEF, Jones TF, Leuwer M, Pearse RM; VISION-UK Investigators; University College Hospital; Royal Liverpool University Hospital; Leeds Teaching Hospitals. Early elevation in plasma high-sensitivity troponin T and morbidity after elective noncardiac surgery: prospective multicentre observational cohort study. British Journal of Anaesthesia. 2020; 124: 535–543.

[34] Kavsak PA, Walsh M, Srinathan S, Thorlacius L, Buse GL, Botto F, et al. High sensitivity troponin T concentrations in patients undergoing noncardiac surgery: a prospective cohort study. Clinical Biochemistry. 2011; 44: 1021–1024.

[35] Antonowicz SS, Cavallaro D, Jacques N, Brown A, Wiggins T, Haddow JB, et al. Remote ischemic preconditioning for cardioprotection in elective inpatient abdominal surgery—a randomized controlled trial. BMC Anesthesiology. 2018; 18: 76.

[36] Ali ZA, Callaghan CJ, Lim E, Ali AA, Nouraei SA, Akthar AM, et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation. 2007; 116: I98–I105.

[37] O’Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979; 35: 549–556.

[38] Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 74: 1124–1136.

[39] Zarbock A, Schmidt C, Van Aken H, Wempe C, Martens S, Zahn PK, et al.; RenalRIPC Investigators. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA. 2015; 313: 2133–2141.

[40] Zangrillo A, Musu M, Greco T, Di Prima AL, Matteazzi A, Testa V, et al. Additive effect on survival of anaesthetic cardiac protection and remote ischemic preconditioning in cardiac surgery: a bayesian network meta-analysis of randomized trials. PLOS ONE. 2015; 10: e0134264.

[41] Meybohm P, Bein B, Brosteanu O, Cremer J, Gruenewald M, Stoppe C, et al.; RIPHeart Study Collaborators. A multicenter trial of remote ischemic preconditioning for heart surgery. The New England Journal of Medicine. 2015; 373: 1397–1407.

[42] Hausenloy DJ, Candilio L, Evans R, Ariti C, Jenkins DP, Kolvekar S, et al.; ERICCA trial investigators. remote ischemic preconditioning and outcomes of cardiac surgery. The New England Journal of Medicine. 2015; 373: 1408–1417.

[43] Rossaint J. Propofol anesthesia and remote ischemic preconditioning: an unfortunate relationship. Anesthesia and Analgesia. 2018; 126: 1118–1120.

[44] Lamidi S, Baker DM, Wilson MJ, Lee MJ. Remote ischemic preconditioning in non-cardiac surgery: a systematic review and meta-analysis. The Journal of Surgical Research. 2021; 261: 261–273.

[45] Arikan MN, Yildiz M, Sen Z, Erel O, Tutar MS, Tire Y, et al. Effect of remote ischemic preconditioning in total knee arthroplasty on thiol-disulfi de balance: a randomized controlled study. Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca. 2023; 90: 314–322.

[46] Asadi M, Hooshmandi E, Emaminia F, Mardani H, Keshtvarz-Hesamabadi AM, Rismanchi M, et al. Safety and efficacy of remote ischemic preconditioning in patients with severe carotid artery stenosis before carotid artery stenting: a proof-of-concept, randomized controlled trial. Current Journal of Neurology. 2022; 21: 119–124.

[47] Gutiérrez Castillo D, San Norberto García EM, García Rivera E, Fidalgo Domingos L, Flota Ruiz CM, Vaquero Puerta C. Effect of remote ischemic preconditioning on the incidence of contrast-induced nephropathy in patients undergoing endovascular aneurysm repair (remote ischemic preconditioning-endovascular aneurysm repair study). Annals of Vascular Surgery. 2022; 86: 338–348.

[48] Chung J, Hur M, Cho H, Bae J, Yoon HK, Lee HJ, et al. The effect of remote ischemic preconditioning on serum creatinine in patients undergoing partial nephrectomy: a randomized controlled trial. Journal of Clinical Medicine. 2021; 10: 1636.

[49] Eerik K, Kasepalu T, Kuusik K, Eha J, Vähi M, Kilk K, et al. Effects of RIPC on the metabolome in patients undergoing vascular surgery: a randomized controlled trial. Biomolecules. 2022; 12: 1312.

[50] Han M, Wu X, Li J, Han S, Rong J. Effects of remote ischemic preconditioning on postoperative cognitive dysfunction in elderly patients with laparoscopic cholecystectomy. International Journal of General Medicine. 2023; 16: 961–971.

[51] Hardt JLS, Pohlmann P, Reissfelder C, Rahbari NN. Remote ischemic preconditioning for reduction of ischemia-reperfusion injury after hepatectomy: a randomized sham-controlled trial. Surgery. 2024; 175: 424–431.

[52] Hardt J, Seyfried S, Brodrecht H, Khalil L, Büttner S, Herrle F, et al. Remote ischemic preconditioning versus sham-control for prevention of anastomotic leakage after resection for rectal cancer (RIPAL trial): a pilot randomized controlled, triple-blinded monocenter trial. International Journal of Colorectal Disease. 2024; 39: 65.

[53] Kong E, Yuan C, Li Y, Tian T, He Y, Feng X. Protective efficiency comparison of direct and remote ischemic preconditioning on ischemia reperfusion injury of the liver in patients undergoing partial hepatectomy. BioMed Research International. 2023; 2023: 2763320.

[54] Kuusik K, Kasepalu T, Zilmer M, Eha J, Vähi M, Torop LA, et al. The role of RIPC in preventing organ damage, inflammation, and oxidative stress during lower limb DSA: a randomised controlled trial. Oxidative Medicine and Cellular Longevity. 2021; 2021: 6043550.

[55] Leung CH, Rizoli SB, Trypcic S, Rhind SG, Battista AP, Ailenberg M, et al. Effect of remote ischemic conditioning on the immune-inflammatory profile in patients with traumatic hemorrhagic shock in a randomized controlled trial. Scientific Reports. 2023; 13: 7025.

[56] Min SH, Choe SH, Kim WS, Ahn SH, Cho YJ. Effects of ischemic conditioning on head and neck free flap oxygenation: a randomized controlled trial. Scientific Reports. 2022; 12: 8130.